Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Solasta Ventures, Inc. is a wholly-owned subsidiary of Aju IB Investment, a prominent South Korean venture capital firm. Established in 2019, Solasta Ventures operates from its office located at Prudential Tower, 800 Boylston Street, Suite 2510, Boston, MA 02199. The firm focuses on investing in innovative companies that aim to improve care for diseases with unmet medical needs. Solasta Ventures leverages scientific expertise and a broad network to identify promising therapeutics and discovery platforms, primarily in the life sciences sector.
As of now, Solasta Ventures has made 29 total investments, with 26 active portfolio companies and 6 notable exits. The firm emphasizes partnerships with strong management teams capable of effectively utilizing capital for long-term value creation. Solasta Ventures has evolved since its inception, transitioning from a US office of Aju IB Investment to a fully incorporated entity in 2019, reflecting its commitment to the North American market.
Solasta Ventures invests primarily in the life sciences sector, specifically targeting therapeutics and technologies that can transform patient care in both U.S. and global markets. The firm seeks to partner with strong management teams that can effectively utilize capital and prioritize assets for long-term value creation. Their investment strategy includes a focus on early-stage startups, particularly those with novel science aimed at advancing the standard of care for diseases with unmet medical needs.
The firm typically invests in Seed, Series A, and Series B stages, with check sizes ranging from $1 million to $10 million. Solasta Ventures actively looks for opportunities for partnerships and collaborations with global pharmaceutical companies, particularly leveraging its extensive network within the South Korean pharmaceutical ecosystem. This strategic approach allows them to enhance the growth potential of their portfolio companies.
Solasta Ventures has a diverse portfolio of 26 companies, primarily in the life sciences sector. Notable portfolio companies include:
These companies represent Solasta Ventures' commitment to investing in innovative therapeutics that address significant medical needs. The firm has also achieved notable exits, further demonstrating its effectiveness in identifying and supporting high-potential ventures.
Derek Yoon - President & CEO. Derek oversees all US-based life science investments and serves on the board of several portfolio companies, including Arcellx and EvolveImmune Therapeutics. He is connected to the Yale Ventures network and has a strong background in biotech.
Katlyn Gabriel - Associate. Katlyn supports investment analysis and portfolio management, contributing to the firm's strategic initiatives.
Nia Julian - Executive Assistant. Nia assists in operational functions and supports the executive team in daily activities.
Michael Jeon - Managing Partner. Michael plays a key role in investment decisions and strategic direction for the firm.
William C. Hahn, M.D., Ph.D. - Scientific Advisory Board. William brings extensive medical and scientific expertise to the firm, advising on portfolio company strategies.
Byoung Chul Cho, M.D., Ph.D. - Scientific Advisory Board. Byoung contributes significant knowledge in life sciences, enhancing the firm's investment strategies.
Startups interested in pitching to Solasta Ventures should visit their website at solasta-ventures.com. It is recommended to include a comprehensive deck that outlines the business model, market analysis, and team qualifications. The firm prefers warm introductions but will consider direct applications through their website. Response times may vary, but founders should expect a thorough review process.
As of April 2023, Solasta Ventures has made significant strides in the life sciences sector, continuing to expand its portfolio with innovative companies. The firm has successfully completed 29 investments, with 6 notable exits, showcasing its effectiveness in identifying high-potential startups.
Recent activities include ongoing support for portfolio companies like Arcellx and EvolveImmune Therapeutics, where Derek Yoon serves on the board, providing strategic guidance and leveraging his extensive network.
What are Solasta Ventures' investment criteria?
Solasta Ventures focuses on innovative companies in the life sciences sector, particularly those with therapeutics and technologies that address unmet medical needs. They prefer to invest in early-stage startups, specifically in Seed, Series A, and Series B rounds.
How can startups apply or pitch to Solasta Ventures?
Startups can pitch to Solasta Ventures through their website at solasta-ventures.com. It is advisable to include a detailed deck that outlines the business model, market opportunity, and team qualifications.
What makes Solasta Ventures different from other VC firms?
Solasta Ventures distinguishes itself through its strong network in South Korea and its focus on life sciences. The firm leverages deep scientific expertise and actively engages with portfolio companies to provide strategic guidance and support for growth.
What is the geographic scope of Solasta Ventures' investments?
Solasta Ventures invests globally, with a particular emphasis on the U.S. market. They seek opportunities that can benefit from their connections within the South Korean pharmaceutical industry.
What is the typical check size for investments?
Solasta Ventures typically invests between $1 million and $10 million in their portfolio companies, depending on the stage and potential of the startup.
What kind of post-investment involvement does Solasta Ventures have?
The firm actively engages with its portfolio companies, providing strategic guidance, operational support, and access to its extensive network, particularly in the South Korean market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.